Success Metrics

Clinical Success Rate
100.0%

Based on 4 completed trials

Completion Rate
100%(4/4)
Active Trials
4(36%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_2
1
9%
Ph not_applicable
7
64%

Phase Distribution

0

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution8 total trials
Phase 2Efficacy & side effects
1(12.5%)
N/ANon-phased studies
7(87.5%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

4 of 4 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

4

trials recruiting

Total Trials

11

all time

Status Distribution
Active(6)
Completed(4)
Other(1)

Detailed Status

Completed4
Active, not recruiting2
Recruiting2
Not yet recruiting1
unknown1
Enrolling by invitation1

Development Timeline

Analytics

Development Status

Total Trials
11
Active
4
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Phase 21 (12.5%)
N/A7 (87.5%)

Trials by Status

not_yet_recruiting19%
active_not_recruiting218%
unknown19%
enrolling_by_invitation19%
completed436%
recruiting218%

Recent Activity

Clinical Trials (11)

Showing 11 of 11 trials
NCT07537569Not Applicable

Preoperative Oncogeriatric Assessment in Patients Undergoing Hepatectomy

Not Yet Recruiting
NCT03894917

Characterizing Disease Biology, Treatment and Toxicity in Older Adults With Hepatocellular Carcinoma

Recruiting
NCT06761534

Development and Verification of a Screening Tool for Comprehensive Geriatric Assessment of Elderly Tumor Patients

Enrolling By Invitation
NCT06890325Not Applicable

A Service-Learning Program for Comprehensive Geriatric Assessment and Health Promotion in Older Adults

Recruiting
NCT04375579

Assessment of Elderly Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Active Not Recruiting
NCT05706272Not Applicable

Secure and Focused Primary Care for Older pEople

Active Not Recruiting
NCT05447533Not Applicable

Clostridioides Difficile and Frailty

Completed
NCT04113226Phase 2

Assessment of Survival and Autonomy With Rituximab Plus Chemotherapy or Rituximab Plus Lenalidomide for Elderly Patients With Relapsed Diffuse Large B-cell Lymphoma

Unknown
NCT02000011Not Applicable

Interest of a Geriatric Intervention Plan Associated to a Comprehensive Geriatric Assessment on Autonomy, Quality of Life and Survival of Patients Aged 70 Years Old and More Surgically Treated for a Resectable Cancer (Thoracic, Digestive or Urologic). Randomized Multicentric Study

Completed
NCT03796923Not Applicable

Models of Care in the Transition From the Secondary to the Primary Sector Among the Frailest Elderly

Completed
NCT03101631Not Applicable

Frailty Evaluation in Elderly Population With Cancer

Completed

All 11 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
11